Normothermic cardiopulmonary bypass increases heparin requirements necessary to maintain anticoagulation

被引:3
|
作者
Ereth, MH [1 ]
Fisher, BR [1 ]
Cook, DJ [1 ]
Nuttall, GA [1 ]
Orszulak, TA [1 ]
Oliver, WC [1 ]
机构
[1] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA
关键词
heparin; anticoagulation; cardiopulmonary bypass; temperature; normothermia; hypothermia;
D O I
10.1023/A:1009987505590
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective. With the practice of warm cardiopulmonary bypass (CPB) at our institution we have observed an apparent increase in heparin requirements. CPB temperature predictability affects pharmacokinetics and differences in drug metabolism can be expected. We hypothesized that heparin requirements would increase with increasing CPB temperature. Methods. Following Institutional Review Board approval, we reviewed the charts of 354 patients undergoing primary coronary artery bypass graft surgery. We recorded patient demographic data, CPB duration, heparin requirements, and temperature during CPB. CPB was conducted between 24 degrees C and 37 degrees C. The Spearman's correlation coefficient, Pearson chi-square, and rank-sum tests were used for data analysis. Results. Core temperature during CPB correlated with heparin requirements (r = 0.13, p < 0.02). However, CPB duration was shorter in warm patients than in cold patients (r = -0.455, p < 0.0001). Additional heparin requirements adjusted for duration of CPB (units/minute) were also significantly greater in the warm group (p = 0.018). Conclusions. Maintenance of adequate heparin anticoagulation during CPB is clinically important. Warm CPB patients required more heparin per minute than those undergoing cold CPB, More frequent assessment of anticoagulation and administration of additional heparin should be considered in patients undergoing warm CPB.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 50 条
  • [41] Heparin-induced antibody formation in patients undergoing cardiopulmonary bypass surgery with bovine or porcine heparin anticoagulation
    Konkle, BA
    Bauer, TL
    Mestichelli, B
    Palermo, C
    Cines, DB
    Poncz, M
    McNulty, S
    Edie, RN
    Mannion, JD
    THROMBOSIS AND HAEMOSTASIS, 1999, : 60 - 60
  • [42] IS NORMOTHERMIC CARDIOPULMONARY BYPASS LINKED TO INCREASE MORBIDITY
    TONZ, M
    MIHALJEVIC, T
    PASIC, M
    VONSEGESSER, LK
    TURINA, M
    HELVETICA CHIRURGICA ACTA, 1993, 60 (03) : 387 - 391
  • [43] Cerebral swelling after normothermic cardiopulmonary bypass
    Harris, DNF
    Oatridge, A
    Dob, D
    Smith, PLC
    Taylor, KM
    Bydder, GM
    ANESTHESIOLOGY, 1998, 88 (02) : 340 - 345
  • [44] MYOCARDIAL REWARMING DURING NORMOTHERMIC CARDIOPULMONARY BYPASS
    REGRAGUI, IA
    IZZAT, MB
    BRYAN, AJ
    ANGELINI, GD
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (03): : 595 - 597
  • [45] Minimum hematocrit for normothermic cardiopulmonary bypass in dogs
    Cook, DJ
    MacVeigh, I
    Orszulak, TA
    Daly, RC
    CIRCULATION, 1996, 94 (08) : 3138 - 3138
  • [46] Comparative study of the protective effect using hypothermic cardiopulmonary bypass and normothermic cardiopulmonary bypass
    HAN PeiliaFU QinglinaZHANG XinzhongbZHANG JieaQIN YuanxucCUI YuaaDepartment of Cardiovascular Surgery
    bDepartment of Neurosurgery
    cDepartment of Anesthesiologythe First Affiliated Hospital of Weihui Medical UniversityXinxiang Henan ProvinceChina
    医学信息(手术学分册), 2007, (12) : 1094 - 1099
  • [47] Cardiopulmonary Bypass Without Heparin
    Rehfeldt, Kent H.
    Barbara, David W.
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2016, 20 (01) : 40 - 51
  • [48] Failure of danaparoid anticoagulation for cardiopulmonary bypass
    Ariano, RE
    Bhattacharya, SK
    Moon, M
    Brownell, LG
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (01): : 167 - 168
  • [49] Anticoagulation for cardiopulmonary bypass: part one
    Cartwright, B.
    Mundell, N.
    BJA EDUCATION, 2023, 23 (03) : 110 - 116
  • [50] Argatroban for anticoagulation during cardiopulmonary bypass
    Martin, ME
    Kloecker, GH
    Patel, A
    Laber, DA
    BLOOD, 2005, 106 (11) : 118B - 118B